0001209191-19-007893.txt : 20190206 0001209191-19-007893.hdr.sgml : 20190206 20190206200207 ACCESSION NUMBER: 0001209191-19-007893 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190204 FILED AS OF DATE: 20190206 DATE AS OF CHANGE: 20190206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLATTERY JOSEPH P CENTRAL INDEX KEY: 0001246530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 19573162 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX, INC. STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-04 0 0000876378 TRANSENTERIX INC. TRXC 0001246530 SLATTERY JOSEPH P C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP and CFO Common Stock 2019-02-04 4 M 0 113778 0.00 A 113778 D Common Stock 2019-02-04 4 F 0 51199 2.57 D 62579 D Common Stock 25000 I By IRA Stock Option 2.47 2019-02-06 4 A 0 526000 0.00 A 2029-02-06 Common Stock 526000 526000 D Restricted Stock Units 2019-02-06 4 A 0 350000 0.00 A Common Stock 350000 350000 D Restricted Stock Units 2019-02-04 4 M 0 59334 0.00 D Common Stock 59334 118666 D Restricted Stock Units 2019-02-04 4 M 0 30000 0.00 D Common Stock 30000 30000 D Restricted Stock Units 2019-02-04 4 M 0 24444 0.00 D Common Stock 24444 0 D This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the restricted stock units in three substantially equal annual installments of 116,667, 116,667 and 116,666 on February 4, 2020, 2021 and 2022 as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. /s/Joshua Weingard, as Attorney-in-Fact for Joseph P. Slattery 2019-02-06